IRIX (IRIDEX) Total Debt to Capital

Public company logo of iridex.com (IRIX)

IRIDEX Corporation (IRIX) is expanding its network of distribution partnerships with ophthalmology centers while avoiding mergers. Market price action on GURU.Markets reflects a total debt-to-equity ratio of 1.08, a critical factor considering the risk of reduced insurance payouts for vision correction. The production cycle relies on a California-based plant featuring strict sterility protocols and a strategic reserve of components.

IRIX: IRIDEX Corp. Debt to Capital 07/04/2022 - 10/29/2026

Analytical breakdowns and data insights for company IRIDEX (IRIX)

- stock quotes and analyst forecast:
Stock Quotes IRIDEX Corp|IRIX - Analyst Forecast Prices
- business market valuation indicators:
Market Capitalization IRIDEX|IRIX - Value Adjusted for Debt and Cash
- book capitalization indicators:
Book Value per Share IRIDEX|IRIX - Total Stockholders' Equity|Market Value to Book Value Ratio iridex.com|IRIX - Aggregate Asset Value
- company total debt and liquidity indicators:
Total Debt to Capital IRIDEX Corporation|IRIX - Long-Term Debt to Capital|Short-Term Debt to Equity IRIDEX Corp|IRIX - Company Aggregate Indebtedness|Debts to Book Capitalization IRIDEX|IRIX - Long-Term Debt|Company Current Liabilities IRIDEX|Quick Liquidity Indicator iridex.com
- earnings and valuation multiples information:
IRIX - Profit After Payment of Taxes
Summary company analytics:IRIDEX Corporation, IRIX
Finished products of IRIDEX Corp

Ensuring the precision delivery of ophthalmological equipment requires significant operational expenditures, making financial leverage control critically important for IRIDEX Corporation (IRIX). By analyzing the dynamics of asset indebtedness, an investor can observe the ratio of total liabilities to equity, which allows for an assessment of the business's resilience to debt load and determines the extent to which the company's growth depends on borrowed financing.

Competitors of IRIDEX Corporation

Total Debt to Equity Ratio DXCM|PEN (Penumbra Inc) - Aggregate Debt to Capital|Total Debt to Capital NOVT|HAE (Haemonetics Company) - All Debt to Shareholders' Equity Ratio|Total Debt to Capital INSP (Inspire Medical Systems)|procept-biorobotics.com (PRCT) - Debt to Capital|CNMD - Debt to Equity|All Debt to Shareholders' Equity Ratio PLSE (Pulse Biosciences Inc)|INMD: Total Debt to Capital|Picard Group (PMI) - Total Debt to Capital|Debt to Equity Surmodics, Inc.|Senseonics Corp - Aggregate Debt to Equity|Total Debt to Capital NPCE|TCMD - Debt to Capital|SANUWAVE Health, Inc. - Total Debt to Equity Ratio|Total Debt to Capital Outset Medical Corp OM|ELMD: Total Debt to Equity Ratio|lensar.com - Aggregate Debt to Capital|RCEL: Total Debt to Capital|PROF - Total Debt to Capital Coefficient|BDMD (Baird Medical Investment Holdings) - Total Debt to Capital|Total Debt to Equity Ratio EDAP Medical (EDAP)|Total Debt to Equity Ratio APYX (Apyx Medical)|ICCM (icecure-medical.com) - All Debt to Shareholders' Equity Ratio|Debt to Equity Pulmonx LUNG|TELA - Total Debt to Equity Ratio|CytoSorbents Corp. - Total Debt to Capital|Debt to Capital Sensus|ZYXI: Total Debt to Capital|Debt to Equity Ratio ECOR|RBOT (Vicarious Surgical Inc) - Total Debt to Capital|Inspira Technologies Oxy B.H.N. Ltd (IINN) - Total Debt to Capital Coefficient|Total Debt to Capital ICU|Total Debt to Equity Ratio ibs.inc INBS|Total Debt to Capital XAIR (Beyond Air)|Total Debt to Capital profusa.com PFSA|SSKN - Debt to Equity|GCTK: Debt to Equity|NAOV (NanoVibronix) - Total Debt to Equity Ratio|Venus Concept Corporation - All Debt to Shareholders' Equity Ratio|NUWE (Nuwellis, Inc.) - Total Debt to Capital|Debt to Capital aethlonmedical.com AEMD|Debt to Equity Asensus Surgical, Inc. (ASXC)|Avinger Inc. (AVGR) - Debt to Capital Ratio|BioSig Technologies, Inc. - Total Debt to Equity Ratio|Total Debt to Capital Cutera Inc CUTR|Know Labs, Inc. - Total Debt to Capital|Total Debt to Capital Coefficient inarimedical.com NARI|Nevro (NVRO) - Debt to Equity|Aggregate Debt to Equity RSLS (ReShape Lifesciences Inc.)|Debt to Equity Silk Road Medical Inc.